logo-loader

Navega Therapeutics

Receive alerts
Market:
Unlisted (US)
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Navega Therapeutics Inc. is a preclinical stage company pursuing a radically different approach to treat chronic pain and tackle the opioid epidemic.